Tricalcium silicate cements have been successfully employed in the biomedical field as bioactive bone and dentin substitutes, with widely acclaimed osteoactive properties. This research analyzed the effects of different tricalcium silicate cement formulations on the temporal osteoactivity profile of human bone marrow-derived mesenchymal stem cells (hMW-MSCs).
Introduction
Bioactivity is one of the most coveted properties of tricalcium silicate cements (TSCs) that is responsible for the continuously-expanding clinical applications of these cements in biomedical tissue engineering. By definition, bioactivity is the ability of a biomaterial to induce a specific biologic response [1] . Tricalcium silicate cements are hydraulic cements wherein their major components, calcium di-and tri-silicates, react with water to form calcium silicate hydrate and calcium hydroxide [2] . The water that is required for these reactions may be derived in vivo from interstitial tissue fluid in the vicinity of the area of application of the TSCs.
Of particular interest to clinicians and researchers is the ability of TSCs to induce osteogenic responses when they are applied to bone defects (i.e. osteoactivity). The literature is replete with studies addressing the osteoactivity of TSCs with the overall results being supportive of their osteogenic potential [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, a closer inspection of this body of literature raises important concerns. For instance, the aforementioned studies employed cell lines from different species to study the osteogenic properties of TSCs. While consensus on the cytotoxicity of a biomaterial may be reached because cytotoxicity ranking is preserved among different cell lines [12] [13] [14] , the same cannot be extended to cell differentiation studies, since different cell lines react differently to the same stimulus [4, 12] . Intraspecies variation is another salient issue; for example, murine MSCs not only from differ from human MSCs, but also differ among various strains in their genetic marker expressions and culture behavior [15] [16] [17] . Another source of confusion arises from the frequent use of fully-or partially-differentiated cell lines with established secretory functions and hard tissue forming potential for analysis of the osteogenic differentiation potential of a biomaterial. Results from these studies only show how well-differentiated cells perform their normal physiologic secretory functions in presence of the 4 biomaterial of interest; they do not provide information on how that biomaterial affects the differentiation of those cells from their immature counterparts.
Bone marrow is a promising source of mesenchymal stem cells (MSCs) for a broad range of cellular therapies in regenerative medicine. Human bone marrow-derived MSCs (hBM-MSCs) provide an excellent model for studying the in vitro osteoactivity of TSCs. They are among the most thoroughly characterized cell lines in the field of regenerative medicine [18] [19] [20] [21] . These cells are pluripotent, undifferentiated adult stem cells with multi-lineage differentiation potential [22] [23] [24] . They may be harvested from the bone marrow relatively easily [25] , and have the ability to differentiate into mature, specialized cells with chondrogenic, osteogenic and adipogenic lineages [22] [23] [24] . To the best of our knowledge, the osteoactive effects of TSCs on hBM-MSCs have not been studied previously. To address this gap in knowledge and to better understand the bioactivity of TSCs, the objective of the present study was to evaluate the effects of several commercial TSC formulations on osteogenic differentiation of hBM-MSCs. Two null hypotheses were tested: i) TSC exposure has no osteogenic effects on hBM-MSCs, and ii) there are no differences among the different commercial TSC formulations in their prospective influences on osteogenic differentiation of hBM-MSCs.
Materials and methods

Materials
The main constituents and primary phases of the tested TSCs are summarized in Table I .
White (WMTA) and gray (GMTA) ProRoot MTA (Dentsply Tulsa Dental Specialties, Tulsa, OK) were mixed with distilled water. White (WMTAP) and gray (GMTAP) MTA Plus (Avalon Biomed Inc, Bradenton, FL) were mixed with the proprietary hydrogel supplied by the manufacturer. These TSCs were mixed in a liquid to powder ratio of 0.3 according to their respective manufacturer's instructions. The mixed materials were placed in pre-sterilized Teflon molds (5-mm diameter and 3-mm thick), covered with pre-sterilized Mylar sheets, and allowed to set in a 100% humidity chamber for 24 hours.
To avoid the initial cytotoxic effects of TSCs as demonstrated in a previous study [26] , a previously-published aging/elution protocol based on the cements' specific cytotoxic profiles was adopted to render the cement discs non-cytotoxic prior to initiation of the experiment [26, 27] . According to this protocol, cement discs were sterilized by UV light for 4 hours, aseptically placed in their respective sterile Transwell® inserts (3.0 micron porous filter, Corning Inc., MA), and immersed in complete culture medium (CCM) for 2 weeks at 37°C in 100% humidity. The CCM consisted of alpha minimum essential medium (αMEM) and 20% fetal bovine serum (Atlanta Biologicals, GA), supplemented with 2 mmol/L L-glutamine (Lonza, Wakersville, MD) and 100 U/mL penicillin G/streptomycin sulfate (Invitrogen Corp, Carlsbad, CA). The culture medium was changed every 3 days to eliminate cytotoxic eluents that may interfere with their bioactive properties.
Cell culture
Previously characterized hBM-MSCs with CD73+/CD105+/CD45− immunophenotype [28] were used in the present study. The cells were received from the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White, through a grant from NCRR of the National Institute of Health, Grant #P40RR017447. This cell line has a subpopulation of small, rapidly-proliferating cells with high multi-differentiation potential that have been identified as rapidly self-renewing cells, among larger mature MSCs with limited differentiation potential and slow proliferation rate [29] . The multi-lineage potential of this cell line has been confirmed in previous studies [18] . For the current experiment, cells 6 from passages 4 to 6 were plated in CCM at 1x10 4 cells/cm 2 . After 24 hours, or after the cells reached ≈70%-80% confluence, Transwells® containing the pre-treated cement discs were placed in their respective wells, and the medium was changed to osteogenic differentiation medium (ODM). The latter consisted of the original CCM, supplemented with 50 mg/mL ascorbic acid, 10 mmol/L β-glycerophosphate, and 100 nmol/L dexamethasone (Sigma-Aldrich, St Louis, MO). The ODM was changed every 3 days. Data output was expressed as fold changes of mRNA expression levels, given by 2 -ΔΔC T [30] .
Expression profiles of target gene markers were compared among test groups.
Western blotting
Western blotting was used to analyze the expression levels of OCN, OPN, OSX, MSX2
and RUNX2 proteins following exposure of the hBM-MSCs to the test TSCs. After 1, 3, 7 and 10 days, cells exposed to different treatments were lysed using Radio Immuno Precipitation Assay buffer with a protease inhibitor cocktail (Sigma-Aldrich). Bicinchoninic acid assay was used to determine the protein concentration per specimen using bovine serum albumin as a standard. Protein denaturing and reduction was accomplished by adding 4X Laemmli buffer (Bio-Rad Laboratories, Hercules, CA) to the specimens, after standardization of the total amount of protein to be loaded, followed by boiling the samples at 100°C for 5 min. where OD is the optical density at 405 nm, and t is the time in min. ODSample 0 is the optical density at 0 min. The resultant data were plotted on a graph, and the peak value for each material was selected and compared with the other materials.
2.6
Alizarin red S assay Extracellular matrix mineralization was assessed both qualitatively and quantitatively by
Alizarin Red S assay [32] . Alizarin red S (AR-S) stains calcium-rich deposits (nodules) produced by cultured cells; the dye may be extracted from the stained nodules and assayed by spectrophotometry. After the hBM-MSCs were exposed to cement discs in ODM for 28 days, the cement discs were retrieved and cells were washed with PBS, fixed in 10% formaldehyde and stained with AR-S (40 mmol/L solution, pH 4.2) for 20 min at room temperature under shaking.
Images of the specimens were taken for qualitative assessment of the stained nodules. The 
Results
qRT-PCR
A detailed presentation of the fold regulation of the expression of target mineralization markers can be found in Figure 1 . Expression of ALP was significantly downregulated at the 4 time-points in all treatment groups compared to the MM control, with maximum downregulation noted at day 7 for all treatment groups. No significant differences were found between ALP expression in treatment groups except between GMTA and WMTA at days 7 and 10, where ALP expression was significantly more downregulated in WMTA compared to GMTA and GMTAP. Figure 2 shows the results of the Western blotting. Expression of RUNX2 among groups was not significantly different at all time-points. Nevertheless, peak values were noted at day 7, after which the protein expression level declined at day 10. For OSX, no differences were found at day 1 and 7 among groups, while WMTAP was significantly downregulated at day 3. All groups were significantly downregulated at day 10. For OPN, only GMTA was significantly downregulated at day 1. No differences were noted among all groups at day 3. WMTA and GMTAP were significantly downregulated at day 7. All groups except GMTA were significantly downregulated at day 10. For MSX2, no differences were found among groups at day 1, while significant downregulation was found in groups GMTA, GMTAP and WMTAP at day 3. MSX2 expression was not detected at days 7 and 10. For OCN, GMTAP was significantly downregulated at day 1, WMTAP at day 3, WMTA at day 7. No difference was found among all groups at day 10. 
Western blotting
ALP assay
3.4
Alizarin red S assay After 28 days of incubation with the TSCs, WMTAP and GMTAP showed higher AR-S levels than WMTA, GMTA and the MM control, but the difference was not statistically significant ( Figure 4A ). All treatment groups showed significantly higher AR-S levels compared to the CCM control ( Figures 4A and 4B ).
Discussion
Human BM-MSCs were employed for the present study due to their robust stemness, pleuripotency, relative ease of harvesting and their clinical significance [18, 20, 25] . Previous 13 studies have reported that TSCs increase the osteogenic potential of osteoblast precursors [33] , pre-odontoblasts [34] , human osteosarcoma cells [3] , periodontal ligament and gingival fibroblast cells [4] , osteoblasts [5] , osteoblast precursor cells [9] , dental pulp stem cells [10] , human tooth germ stem cells [35] . To our knowledge, this is the first study that examined the effects of TSCs on the osteoactivity of a pleuripotent, human adult MSC cell line derived from the bone marrow.
The present study employed a multi-parameter approach to study the temporal expression profiles of osteogenic differentiation determinants by tracking the four major molecular events in osteogenesis: mRNA expression of osteogenic markers using qRT-PCR, protein expression using Western blotting, and intracellular ALP enzyme level, all at strategic time points following exposure to the test cements. This was followed by quantification of extracellular calcium deposition and matrix mineralization using AR-S assay after 28 days of exposure to the test cements. This enabled us to monitor the intra-and extra-cellular events that altered the translational, transcriptional, enzymatic and hard tissue forming levels over the length of the experiment.
The following 6 markers, ALP, RUNX2, OCN, OPN, MSX2 and OSX were chosen for examination of osteogenic differentiation in the present study. ALP appears to be intimately related to pre-osseous cellular metabolism and to the elaboration of a calcifiable bone matrix [36] . RUNX2 is a transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. This transcription factor has been shown to effectuate the expression of OSX, collagen type 1 alpha-1 (Col1a1), OCN and OPN by binding to the promoters of these genes [37] . Generally, RUNX2, ALP, Col1a1, transforming growth factor-beta 1 (TGF-1), osteonectin and bone morphogenetic protein-2 are known to be early markers of osteoblastic differentiation, whereas OCN and OPN are expressed later in the differentiation process [38] .
MSX2 promotes osteoblast differentiation and bone formation by upregulating osterix in a RUNX-dependent manner [39] . OSX is a zinc finger-containing transcription factor, specifically expressed in all developing bones. The protein produced is a bone specific transcription factor and is required for osteoblast differentiation and bone formation [40] .
The presence study found no evidence of osteoactivity of TSCs on hBM-MSCs up to 28 days of exposure of these cells to the tested cements. On the contrary, results derived from mRNA and protein analyses indicate that exposure of hBM-MSCs to TSCs over the designated time periods inhibited osteogenic differentiation when compared with cells that were not exposed The Wnt/β-catenin pathway has been associated in skeletogenesis, bone development and homeostasis [41] . Wnt signaling pathway has differential effects on osteogenesis, which are dependent on the stage of cellular differentiation of the recipient cells [42] . Activation of Wnt/βcatenin signaling pathway has been shown to prevent transdifferentiation of osteoblast to chondrocytes [43] , while at the same time inhibiting osteogenic differentiation of BM-MSCs [44] . In a recent article investigating the relationship between the intracellular pH and the Wnt/βcatenin signaling in cancer cells, cross-talk was found between intracellular pH and Wnt signaling pathway activation [45] .
A more recent article studied the effects of silicon (Si) on the sonic hedgehog and Wnt signaling pathways, as well as expression of osteogenic markers in BMSCs. AXIN2 and βcatenin, two WNT/SHH signaling related genes, were upregulated in response to Si [46] . Furthermore, Si counteracted the effect of cardamonin, a major Wnt signaling pathway inhibitor.
A noteworthy observation in that study is that the Si concentration at which β-catenin was [47] . Tuli and colleagues [48] demonstrated that TGF-β 1 treatment initiates and maintains chondrogenesis of MSCs, through the differential chondrostimulatory activities of p38, ERK-1 and JNK in the early steps of MSC chondrogenesis. Transcriptional profiling of MSCs revealed that TGF-β was significant in chondrogenesis, but axonal guidance pathway was significant in adipogenesis and osteogenesis. Furthermore, inhibition of ALK-5 (TGF-β type I receptor)mediated TGF-β signaling resulted in enhanced adipogenic and osteogenic differentiation, but a complete lack of chondrogenic differentiation [49] . Previous studies have shown that TSCs release TGF-β from gingival fibroblasts [50, 51] . Thus, inhibition of osteogenic differentiation of MSCs by activation of TGF-β signaling pathway after exposure to TSCs may be a potential consequence.
Conclusion
In conclusion, the present study did not find any in vitro evidence that TSCs can induce 
